Latest Publications
Hot off the Press: Recent Publications from Improved Pharma and Varda Space Industries Collaboration
Improved Pharma contributes to dual publications detailing the successful recovery and analysis of a metastable form of Ritonavir space-generated, and the single crystal growth and structure solution of Nirmatrelvir Form 2. WEST LAFAYETTE, Ind.,Read more
Improved Pharma Scientists to Present at Spring Pharmaceutical Synchrotron-XRPD Workshop May 6-8 in Basel, Switzerland
Using Orthogonal Techniques to Probe for Detectable Crystalline API in Amorphous Dispersions WEST LAFAYETTE, Ind., April 21, 2026 /PRNewswire/ -- Detecting crystalline domains in amorphous materials can be critical for shelf-life stability of pharmaceuticals.Read more
Improved Pharma Expands Pharmaceutical Development Services with New Automated Dissolution Capabilities
Dissolution-Instrument-Based Strategies to De-Risk and Accelerate Pharmaceutical Development WEST LAFAYETTE, Ind., Feb. 11, 2026 /PRNewswire/ -- Improved Pharma, a leader in pharmaceutical research and solid-state chemistry, is pleased to announce a significant upgrade to its analyticalRead more
Dissolution-Instrument-Based Strategies to De-Risk and Accelerate Pharmaceutical Development
Steve Byrn and David Engers Improved Pharma Feb. 11, 2026 Improved Pharma has recently expanded its dissolution capabilities by installing a fully automated Agilent 708-DS dissolution apparatus paired with the 850-DS autosampler. This capabilityRead more
Improved Pharma Announces Enhanced X-Ray Diffraction and Interpretation Services to Strengthen Market Authorization Applications and Patents
Expanded solid-state characterization services now deliver advanced X-ray diffraction, expert interpretation, and regulatory-ready data for market authorization and patents. WEST LAFAYETTE, Ind., Feb. 9, 2026 /PRNewswire/ -- Improved Pharma is pleased to announce the expansion ofRead more
The High-Quality Difference: Solid-State Data That Stands Up to FDA and Patent Review
Authors Jared Smit, David Engers, Steve Byrn In modern small-molecule development, solid-state characterization is far more than a routine analytical task.(Byrn, Zografi et al. 2025) It defines the manufacturable form of an API, supportsRead more
Solving Pharmaceutical Problems
We are a research and information company dedicated to improving pharmaceutical methods, formulations, and processes.